Understanding Probiotics and COVID-19 link: Key points for Indian Practitioners
While the recommendations regarding the strain, dose, and duration of probiotic are yet to be well established; given the large experience of clinical usage, and evidence for beneficial effects in various clinical settings, Lactobacillus and Bifidobacterium can safely be used 1
Severe acute respiratory syndrome Coronavirus-2 (SARS nCoV-2), causing Coronavirus disease 2019 (COVID-19) remains a continuously progressing pandemic with 25,118,689 (about 2.5 crores) cases and 844,312 (about 8.5 lakhs) deaths all over the world with a mortality rate of 3.4% as estimated by the WHO database at the end of August 2020 1 . The major reasons for massive impact of COVID-19 seem to be lack of preparedness for such unprecedented transmission, intrinsic virulence of the pathogen and its contagiousness, asymptomatic spreaders, unavailability of a vaccine, and lack of effective antiviral agents 2 . In the light of emerging pathophysiological targets in COVID-19, the consideration of probiotics seems justified and clinical evidence in this direction is evolving rapidly.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Before Joining Medical Dialogues, he has served at important positions in the medical industry in India including as the Hony. Secretary of the Delhi Medical Association as well as the chairman of Anti-Quackery Committee in Delhi and worked with other Medical Councils in India. Email: firstname.lastname@example.org. Contact no. 011-43720751